{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:48:31Z","timestamp":1791362911287,"version":"4.3.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jdermsci.2011.11.007","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T16:26:59Z","timestamp":1322756819000},"page":"4-11","source":"Crossref","is-referenced-by-count":101,"title":["Chemokine receptors in the pathogenesis and therapy of psoriasis"],"prefix":"10.1016","volume":"65","author":[{"given":"Tomotaka","family":"Mabuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Quinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam T.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2011.11.007_bib0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis \u2013 epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(02)00142-1","article-title":"A survey of psoriasis patients in Japan from 1982 to 2001","volume":"31","author":"Kawada","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Cyclosporin A for psoriasis","volume":"301","author":"Mueller","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bmj.293.6549.731","article-title":"Clearance of psoriasis with low dose cyclosporin","volume":"293","author":"Griffiths","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0025","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of CLA+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/jid.2010.280","article-title":"Resolved psoriasis lesions retain expression of a subset of disease-related genes","volume":"131","author":"Suarez-Farinas","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nm0202-157","article-title":"CCL27\u2013CCR10 interactions regulate T cell-mediated skin inflammation","volume":"8","author":"Homey","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0040","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2009.122","article-title":"Chemokine receptors in T-cell-mediated diseases of the skin","volume":"129","author":"Lonsdorf","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0045","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ni.f.213","article-title":"Orchestrating the orchestrators: chemokines in control of T cell traffic","volume":"9","author":"Bromley","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades","volume":"410","author":"Chang","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0065","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0070","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0075","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0085","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0090","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0095","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1038\/jid.2010.166","article-title":"Effective narrow-band UVB radiation therapy suppresses the IL-23\/IL-17 axis in normalized psoriasis plaques","volume":"130","author":"Johnson-Huang","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0105","doi-asserted-by":"crossref","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0110","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0115","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0120","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1172\/JCI37378","article-title":"CCR6 is required for IL-23-induced psoriasis-like inflammation in mice","volume":"119","author":"Hedrick","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4049\/jimmunol.180.1.122","article-title":"Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells","volume":"180","author":"Lim","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/bbrc.1997.6936","article-title":"STRL22 is a receptor for the CC chemokine MIP-3a","volume":"236","author":"Liao","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0135","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.186.6.837","article-title":"CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3a and is highly expressed human dendritic cells","volume":"186","author":"Greaves","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0140","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1084\/jem.186.6.825","article-title":"Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3\u03b1 from lung dendritic cells","volume":"186","author":"Power","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0145","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","article-title":"Up-regulation of macrophage inflammatory protein-3a\/CCL20 and CC chemokine receptor 6 in psoriasis","volume":"164","author":"Homey","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0150","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.4049\/jimmunol.165.12.6677","article-title":"Cutting edge: CC chemokine receptor-6 (CCR6) is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro","volume":"165","author":"Fitzhugh","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.sder.2010.03.001","article-title":"New insights in the immunologic basis of psoriasis","volume":"29","author":"Nograles","year":"2010","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0160","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1517\/14728222.2010.504716","article-title":"CCR6 as a possible therapeutic target in psoriasis","volume":"14","author":"Hedrick","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","article-title":"The CC chemokine CCL20 and its receptor CCR6","volume":"14","author":"Schutyser","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.286.5439.525","article-title":"\u03b2-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6","volume":"286","author":"Yang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0175","first-page":"982","article-title":"\u03b3\u03b4+ T cells from patients with psoriatic and rheumatoid arthritis respond to streptococcal antigen","volume":"20","author":"Grinlinton","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0180","first-page":"15","article-title":"Cellular interactions and adhesion molecules in psoriatic skin","volume":"186","author":"de Boer","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0185","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1600-0560.2007.00756.x","article-title":"Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor \u03b3\u03b4 in plaque and guttate psoriasis","volume":"34","author":"Seung","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0190","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.1100804","article-title":"Identification of a novel proinflammatory human skin-homing V\u03b39V\u03b42T cell subset with a potential role in psoriasis","volume":"187","author":"Laggner","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from \u03b3\u03b4 T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0200","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.4049\/jimmunol.1100427","article-title":"Cutting edge: identification of a motile IL-17-producing \u03b3\u03b4 T cell population in the dermis","volume":"186","author":"Gray","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0205","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.20012000","article-title":"Resident skin-specific \u03b3\u03b4 T cells provide local, nonredundant regulation of cutaneous inflammation","volume":"195","author":"Girardi","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.jid.5700003","article-title":"Immunosurveillance and immunoregulation by \u03b3\u03b4 T cells","volume":"126","author":"Girardi","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0215","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.4049\/jimmunol.1101817","article-title":"Epidermal CCR6+ \u03b3\u03b4 T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis","volume":"187","author":"Mabuchi","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0220","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0225","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.4049\/jimmunol.167.10.5594","article-title":"IL-10 induces CCR6 expression during Langerhans cell development while IL-4 and IFN-\u03b3 suppress it","volume":"167","author":"Dieu-Nosjean","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.192.5.705","article-title":"Macrophage inflammatory protein 3\u03b1 is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors","volume":"192","author":"Dieu-Nosjean","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0235","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/sj.jid.5700799","article-title":"Early inflammatory changes in the \u201cperilesional skin\u201d of psoriatic plaques: is there interaction between dendritic cells and keratinocytes?","volume":"127","author":"Komine","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0240","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-\u03b1 and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0250","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.jid.5700310","article-title":"Prominent production of IL-20 by CD68+\/CD11c+ myeloid-derived cells in psoriasis: gene regulation and cellular effects","volume":"126","author":"Wang","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/00015550410034444","article-title":"Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis","volume":"84","author":"Vestergaard","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00403-007-0764-7","article-title":"Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor","volume":"299","author":"de Groot","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0265","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO;2-Z","article-title":"The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions","volume":"184","author":"Goebeler","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0270","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780242","article-title":"Potential role of the chemokine receptors CXCR3, CCR4, and the integrin \u03b1E\u03b27 in the pathogenesis of psoriasis vulgaris","volume":"81","author":"Rottman","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0275","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/eji.200737370","article-title":"The chemokine receptor CCR6 is an important component of the innate immune response","volume":"37","author":"Wen","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0280","doi-asserted-by":"crossref","first-page":"e4725","DOI":"10.1371\/journal.pone.0004725","article-title":"\u03b2-Defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin","volume":"4","author":"Jansen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.2007.48","article-title":"Psoriasis is associated with increased \u03b2-defensin genomic copy number","volume":"40","author":"Hollox","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00403-009-0966-2","article-title":"Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions","volume":"302","author":"Chen","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0295","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.clindermatol.2007.11.003","article-title":"Chemokines and other mediators as therapeutic targets in psoriasis vulgaris","volume":"26","author":"Homey","year":"2008","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0300","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2005.11.001","article-title":"Chemokine blockers \u2013 therapeutics in the making?","volume":"27","author":"Wells","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0305","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1523-1747.ep12523566","article-title":"Identification of C5adesarg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales","volume":"87","author":"Schroder","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0310","first-page":"63","article-title":"RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol)","volume":"138","author":"Fukuoka","year":"1998","journal-title":"AAD Rev"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/000155599750011615","article-title":"Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis","volume":"79","author":"Raychaudhuri","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0320","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0325","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nchembio.662","article-title":"Ligand discovery from a dopamine D(3) receptor homology model and crystal structure","volume":"7","author":"Carlsson","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0330","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1021\/ja1002263","article-title":"Targeting SDF-1\/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design","volume":"132","author":"Veldkamp","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2177\/jsci.32.85","article-title":"Jak inhibitor; possibility and mechanism as a new disease modifying anti-rheumatic drug","volume":"32","author":"Yamaoka","year":"2009","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0340","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/BOR.0b013e3283378e6f","article-title":"Kinase inhibitors: a new approach to rheumatoid arthritis treatment","volume":"22","author":"Cohen","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0345","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1073\/pnas.91.14.6374","article-title":"Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes","volume":"91","author":"Kawamura","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0350","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.intimp.2008.09.011","article-title":"Effect of orally administered KF66490, a phosphodiesterase 4 inhibitor, on dermatitis in mouse models","volume":"9","author":"Harada","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0355","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current status","volume":"155","author":"Spina","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0360","first-page":"1236","article-title":"AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis","volume":"10","author":"Nazarian","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0365","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/187152807780077318","article-title":"Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis","volume":"6","author":"Baumer","year":"2007","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0370","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1021\/jm100181s","article-title":"2-Imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists","volume":"53","author":"Bolli","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0375","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1067\/mai.2001.114707","article-title":"Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines","volume":"107","author":"Giustizieri","year":"2001","journal-title":"J Allergy Clin Immun"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0380","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/intimm\/dxf109","article-title":"Preferential expression of T(h)2-type chemokine and its receptor in atopic dermatitis","volume":"14","author":"Uchida","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0385","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2230.2004.01638.x","article-title":"Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris","volume":"29","author":"Teraki","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0390","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1034\/j.1398-9995.2001.056002194.x","article-title":"The C-C chemokines, RANTES and eotaxin, in atopic dermatitis","volume":"56","author":"Morita","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0395","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1067\/mai.2003.114","article-title":"Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris","volume":"111","author":"Kakinuma","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0400","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-2133.2007.08200.x","article-title":"CTACK\/CCL27 expression in psoriatic skin and its modification after administration of etanercept","volume":"157","author":"Campanati","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0405","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.4049\/jimmunol.151.8.4399","article-title":"Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro","volume":"151","author":"Schulz","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0410","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1523-1747.1998.00074.x","article-title":"The CXC receptor 2 is overexpressed in psoriatic epidermis","volume":"110","author":"Kulke","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0415","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/1523-1747.ep12371803","article-title":"Differential expression of GRO-\u03b1 and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo","volume":"107","author":"Gillitzer","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0420","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1034\/j.1398-9995.2003.00062_2.x","article-title":"IP-10 in atopic dermatitis","volume":"58","author":"Yamashita","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0425","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4161\/derm.1.2.7750","article-title":"Overexpression of CXCL16 in lesional psoriatic skin","volume":"1","author":"Oh","year":"2009","journal-title":"Dermatoendocrinology"},{"key":"10.1016\/j.jdermsci.2011.11.007_bib0430","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1172\/JCI11517","article-title":"Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses","volume":"107","author":"Fraticelli","year":"2001","journal-title":"J Clin Invest"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181111003239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181111003239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T10:31:22Z","timestamp":1686479482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181111003239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0923181111003239"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2011.11.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}